Brief: Xvivo Q1 EBIT SEK 26.6 Million
Apr 24 (Reuters) - Xvivo Q1 net income SEK -12.4 million. Q1 sales SEK 218.6 million Q1 EPS SEK -0.39 Q1 adjusted EBIT SEK 29.8 million
Recent news on Xvivo Perfusion AB
See all newsSweden's XVIVO Q3 revenue beat expectations on thoracic sales
Brief: Xvivo Q3 EBIT SEK 28 Million
Brief: Xvivo Receives CE Certificates For Heart Preservation Technology
Brief: XVIVO Gets FDA Approval For Additional Patient Enrollment
Sweden's XVIVO Q2 sales beat estimates, helped by thoracic segment strength